MedPath

AZELASTINE HYDROCHLORIDE

479 - Azelastine hydrochloride

Approved
Approval ID

cc7ddac6-95fa-4bc0-824d-f80e404e8d32

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 2, 2025

Manufacturers
FDA

Allegiant Health

DUNS: 079501930

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

AZELASTINE HYDROCHLORIDE

PRODUCT DETAILS

NDC Product Code69168-479
Application NumberANDA216421
Marketing CategoryC73584
Route of AdministrationNASAL
Effective DateMay 2, 2025
Generic NameAZELASTINE HYDROCHLORIDE

INGREDIENTS (8)

AZELASTINE HYDROCHLORIDEActive
Quantity: 202.5 ug in 1 1
Code: 0L591QR10I
Classification: ACTIB
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
SUCRALOSEInactive
Code: 96K6UQ3ZD4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AZELASTINE HYDROCHLORIDE - FDA Drug Approval Details